Frequency and impact of KRAS mutation in early onset colorectal cancer

Affiliations

¹ Surgery Department, University Hospital 12 de Octubre, Madrid E-28041, Spain; Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid, Spain. Electronic address: josepereag@hotmail.com.
² Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain.
³ Pathology Department, University Hospital 12 de Octubre, Madrid E-28041, Spain.
⁴ Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain; Molecular Biology Laboratory, University Hospital 12 de Octubre, Madrid E-28041, Spain.
⁵ Molecular Medicine Unit, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
⁶ Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
⁷ Familial Cancer Clinical Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.

Comment

José Perea et al. Hum Pathol. 2017 Mar.

. 2017 Mar:61:221-222.

doi: 10.1016/j.humpath.2016.07.039. Epub 2016 Nov 2.

¹ Surgery Department, University Hospital 12 de Octubre, Madrid E-28041, Spain; Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid, Spain. Electronic address: josepereag@hotmail.com.
² Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain.
³ Pathology Department, University Hospital 12 de Octubre, Madrid E-28041, Spain.
⁴ Digestive Cancer Research Group, 12 de Octubre Research Institute, Madrid E-28041, Spain; Molecular Biology Laboratory, University Hospital 12 de Octubre, Madrid E-28041, Spain.
⁵ Molecular Medicine Unit, Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
⁶ Biomedical Research Institute of Salamanca (IBSAL), Institute of Molecular and Cellular Biology of Cancer (IBMCC), University of Salamanca-USAL-CSIC, E-37008 Salamanca, Spain.
⁷ Familial Cancer Clinical Unit, Spanish National Cancer Centre (CNIO), Madrid, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.

No abstract available

Comment on

High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
Watson R, Liu TC, Ruzinova MB. Watson R, et al. Hum Pathol. 2016 Oct;56:163-70. doi: 10.1016/j.humpath.2016.06.010. Epub 2016 Jun 23. Hum Pathol. 2016. PMID: 27346571